頭頸部がんの生存者における大麻使用の特徴
Talia A Wenger1, Tyler J Gallagher2, Niels C Kokot2
1Keck School of Medicine of the University of Southern California Los Angeles California USA.
Laryngoscope investigative otolaryngology
|August 27, 2025
まとめ
症状の管理とレクリエーションのために大麻の使用は頭頸部がんの生存者の間で一般的です. 大麻の使用に関する情報をもっと欲しがる人も多いが,信頼できる情報源から入手できる人は少ない.
科学分野:
- 腫瘍学
- カンナビノイド科学
- 癌 の 生存 率
背景:
- 頭頸部がん (HNC) の生存者はしばしば他の治療法を探求する症状を経験します.
- カンナビスは,がん患者の症状管理と健康改善に役立つ可能性があるとますます議論されています.
研究 の 目的:
- HNCの生存者における使用頻度,モード,使用理由を含む大麻使用パターンの特徴づけ.
- がん治療における大麻使用に関する情報に関するHNC生存者の情報源と関心度の評価
主な方法:
- HNCの生存者にResearchMatchとオンラインのサポートグループを通じて横断的な調査が行われました.
- 収集されたデータには,人口統計,がん歴,大麻使用の詳細,およびショートフォーム12アンケートが含まれています.
- 多変量ロジスティック回帰と記述的統計がデータ分析に使用されました.
主要な成果:
- 92人の回答者の75%が現在のまたは以前の大麻使用者でした.
- カンナビス使用者は,平均以上の家計収入を持ち,米国外に住む可能性が低い.
- 疼痛緩和 (79.4%),睡眠改善 (76.5%),ストレスの対処 (64.7%),レクリエーション (63.6%) を含む. 食用品は最も多い消費形態 (46.4%) であった.
結論:
- 大麻の使用は,HNCの生存者の中で,がんに関連した症状の管理とレクリエーション目的で一般的です.
- 大麻使用に関する情報を得ることに興味を示していますが,信頼性の高い情報源からこの情報を得ることに大きなギャップがあります.
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
326
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
326


